CoChat

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project

Open access
Ebenau, Jarith L., Timmers, Tessa, Wesselman, Linda M.P., Verberk, Inge M.W., Verfaillie, Sander C.J., Slot, Rosalinde E.R., van Harten, Argonde C., Teunissen, Charlotte E., Barkhof, Frederik, van den Bosch, Karlijn A., van Leeuwenstijn, Mardou, Tomassen, Jori, Braber, Anouk den, Visser, Pieter Jelle, Prins, Niels D., Sikkes, Sietske A.M., Scheltens, Philip, van Berckel, Bart N.M., van der Flier, Wiesje M. · 2020 · Neurology

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To investigate the relationship between the ATN classification system (amyloid, tau, neurodegeneration) and risk of dementia and cognitive decline in individuals with subjective cognitive decline (SCD). METHODS: We classified 693 participants with SCD (60 ± 9 years, 41% women, Mini-Mental State Examination score 28 ± 2) from the Amsterdam Dementia Cohort and Subjective Cognitive Impairment Cohort (SCIENCe) project according to the ATN model, as determined by amyloid PET or CSF β-amyloid (A), CSF p-tau (T), and MRI-based medial temporal lobe atrophy (N). All underwent extensive neuropsychological assessment. For 342 participants, follow-up was available (3 ± 2 years). As a control population, we included 124 participants without SCD. RESULTS: Fifty-six (n = 385) participants had normal Alzheimer disease (AD) biomarkers (A-T-N-), 27% (n = 186) had non-AD pathologic change (A-T-N+, A-T+N-, A-T+N+), 18% (n = 122) fell within the Alzheimer continuum (A+T-N-, A+T-N+, A+T+N-, A+T+N+). ATN profiles were unevenly distributed, with A-T+N+, A+T-N+, and A+T+N+ containing very few participants. Cox regression showed that compared to A-T-N-, participants in A+ profiles had a higher risk of dementia with a dose-response pattern for number of biomarkers affected. Linear mixed models showed participants in A+ profiles showed a steeper decline on tests addressing memory, attention, language, and executive functions. In the control group, there was no association between ATN and cognition. CONCLUSIONS: Among individuals presenting with SCD at a memory clinic, those with a biomarker profile A-T+N+, A+T-N-, A+T+N-, and A+T+N+ were at increased risk of dementia, and showed steeper cognitive decline compared to A-T-N- individuals. These results suggest a future where biomarker results could be used for individualized risk profiling in cognitively normal individuals presenting at a memory clinic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000009724

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Distribution of the ATN biomarker profiles in subjective cognitive decline Pie chart illustrates the distribution of the 8-profile and 3-category ATN classification. AD = Alzheimer disease.
Figure 1 Distribution of the ATN biomarker profiles in subjective cognitive decline Pie chart illustrates the distribution of the 8-profile and 3-category ATN classification. AD = Alzheimer disease.CC BY-NC-ND · PubMed Central
Figure 2 Kaplan-Meier curves illustrating clinical progression in subjective cognitive decline Kaplan-Meier curves illustrate clinical progression to dementia (A) and to mild cognitive impairment or dementia (B). Separate lines represent the 8 ATN biomarker profiles. The numbers at risk for time points 0, 1, 2, 3, 4, and 5 years are depicted below the figure.
Figure 2 Kaplan-Meier curves illustrating clinical progression in subjective cognitive decline Kaplan-Meier curves illustrate clinical progression to dementia (A) and to mild cognitive impairment or dementia (B). Separate lines represent the 8 ATN biomarker profiles. The numbers at risk for time points 0, 1, 2, 3, 4, and 5 years are depicted below the figure.CC BY-NC-ND · PubMed Central
Figure 3 Spaghetti plots illustrating raw neuropsychological test performance over time in subjective cognitive decline Spaghetti plots show individual neuropsychological trajectories on 6 neuropsychological tests: (A) Visual Association Test version A (VAT-A); (B) Rey Auditory Verbal Learning Test (RAVLT) delayed recall; (C) animal fluency; (D) Trail-Making Test, part A (TMT-A); (E) Stroop I; (F) Stroop III. Separate lines represent the unadjusted mean trajectory of the 8 ATN profiles with 95% confidence intervals. Figures represent raw test scores.
Figure 3 Spaghetti plots illustrating raw neuropsychological test performance over time in subjective cognitive decline Spaghetti plots show individual neuropsychological trajectories on 6 neuropsychological tests: (A) Visual Association Test version A (VAT-A); (B) Rey Auditory Verbal Learning Test (RAVLT) delayed recall; (C) animal fluency; (D) Trail-Making Test, part A (TMT-A); (E) Stroop I; (F) Stroop III. Separate lines represent the unadjusted mean trajectory of the 8 ATN profiles with 95% confidence intervals. Figures represent raw test scores.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 207

Metadata

Authors
Ebenau, J. L., Timmers, T., Wesselman, L. M. P., Verberk, I. M. W., Verfaillie, S. C. J., Slot, R. E. R., van Harten, A. C., Teunissen, C. E., Barkhof, F., van den Bosch, K. A., van Leeuwenstijn, M., Tomassen, J., Braber, A. D., Visser, P. J., Prins, N. D., Sikkes, S. A. M., Scheltens, P., van Berckel, B. N. M., & van der Flier, W. M.
Affiliations
  • Karolinska Institutet (SE)
  • From the Alzheimer Center, Department of Neurology (J.L.E., T.T., L.M.P.W., I.M.W.V., R.E.R.S., A.C.v.H., K.A.v.d.B., M.v.L., J.T., A.d.B., P.J.V., N.D.P., S.A.M.S., P.S., B.N.M.v.B., W.M.v.d.F.), and Department of Radiology & Nuclear Medicine (S.C.J.V., F.B., B.N.v.B.), Amsterdam Neuroscience, Neurochemistry Laboratory, Department of Clinical Chemistry (I.M.W.V., C.E.T.), and Department of Epidemiology & Biostatistics (W.M.v.d.F.), Vrije Universiteit Amsterdam, Amsterdam UMC, the...
Corresponding author
Ebenau, Jarith L.
Venue
Neurology
Published
2020-07-07
Volume
95
Issue
1
Pages
e46-e58
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3033804370
Cited by
191
References
55
Citations by year
2026: 7 · 2025: 43 · 2024: 42 · 2023: 40 · 2022: 33 · 2021: 24 · 2020: 1
FWCI
17.88
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Neurology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
  • VU Research Portal (publishedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
ZonMw (73305095005)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords
subjective cognitive decline, Alzheimer's disease, amyloid PET, medial temporal lobe atrophy, dementia risk, cognitive decline, biomarker profiles, memory clinics
MeSH terms
Aged, Alzheimer Disease, Female, Humans, Male, Middle Aged, Nerve Degeneration, Biomarkers, Amyloid beta-Peptides, tau Proteins, Disease Progression, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project. https://app.cochat.ai/papers/10.1212/wnl.0000000000009724
The paper
Ebenau, J. L., Timmers, T., Wesselman, L. M. P., Verberk, I. M. W., Verfaillie, S. C. J., Slot, R. E. R., van Harten, A. C., Teunissen, C. E., Barkhof, F., van den Bosch, K. A., van Leeuwenstijn, M., Tomassen, J., Braber, A. D., Visser, P. J., Prins, N. D., Sikkes, S. A. M., Scheltens, P., van Berckel, B. N. M., & van der Flier, W. M. (2020). ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project. Neurology. https://doi.org/10.1212/wnl.0000000000009724

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.